Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

FDA Begins Action To Remove Ingestible Fluoride Prescription Drug Products for Children from the Market

  • Post author:PacConAdmin
  • Post published:May 13, 2025
  • Post category:Uncategorized

FDA begins action to remove unapproved fluoride drug products from the market for the well-being of children Source: FDA Press Releases

Continue ReadingFDA Begins Action To Remove Ingestible Fluoride Prescription Drug Products for Children from the Market

HHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula

  • Post author:PacConAdmin
  • Post published:May 13, 2025
  • Post category:Uncategorized

Today, the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) announced the next steps in Operation Stork Speed Source: FDA Press Releases

Continue ReadingHHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula

HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers

  • Post author:PacConAdmin
  • Post published:May 13, 2025
  • Post category:Uncategorized

HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers Source: FDA Press Releases

Continue ReadingHHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers

FDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program

  • Post author:PacConAdmin
  • Post published:May 9, 2025
  • Post category:Uncategorized

FDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program Source: FDA Press Releases

Continue ReadingFDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program

FDA Approves Three Food Colors from Natural Sources

  • Post author:PacConAdmin
  • Post published:May 9, 2025
  • Post category:Uncategorized

The U.S. Food and Drug Administration today announced it granted three new color additive petitions that will expand the palette of available colors from natural sources for manufacturers to safely…

Continue ReadingFDA Approves Three Food Colors from Natural Sources

FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline

  • Post author:PacConAdmin
  • Post published:May 8, 2025
  • Post category:Uncategorized

FDA announced an aggressive timeline to scale AI across all centers by June 30. Source: FDA Press Releases

Continue ReadingFDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline

FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities

  • Post author:PacConAdmin
  • Post published:May 6, 2025
  • Post category:Uncategorized

The U.S. Food and Drug Administration announced its intent to expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended…

Continue ReadingFDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities

HHS, FDA to Phase Out Petroleum-Based Synthetic Dyes in Nation’s Food Supply

  • Post author:PacConAdmin
  • Post published:April 22, 2025
  • Post category:Uncategorized

The U.S. Department of Health and Human Services and FDA today announced a series of new measures to phase out all petroleum-based synthetic dyes from the nation’s food supply—a significant…

Continue ReadingHHS, FDA to Phase Out Petroleum-Based Synthetic Dyes in Nation’s Food Supply

FDA Commissioner Makary Announces New Policy on Individuals Serving on FDA Advisory Committees

  • Post author:PacConAdmin
  • Post published:April 17, 2025
  • Post category:Uncategorized

FDA Commissioner Martin A. Makary, M.D., M.P.H. announces a policy directive that limits individuals employed at companies regulated by the FDA from serving as official members on FDA advisory committees,…

Continue ReadingFDA Commissioner Makary Announces New Policy on Individuals Serving on FDA Advisory Committees

FDA Honored to Welcome HHS Secretary Robert F. Kennedy, Jr. to FDA Campus

  • Post author:PacConAdmin
  • Post published:April 11, 2025
  • Post category:Uncategorized

The U.S. Food and Drug Administration today welcomed HHS Secretary Robert F. Kennedy, Jr. to its headquarters in Silver Spring, Maryland, a visit that included remarks to FDA employees, meetings…

Continue ReadingFDA Honored to Welcome HHS Secretary Robert F. Kennedy, Jr. to FDA Campus
  • Go to the previous page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 143
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company